Prolgolimab
Modify Date: 2024-04-11 15:46:31
Prolgolimab structure
|
Common Name | Prolgolimab | ||
|---|---|---|---|---|
| CAS Number | 2093956-19-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ProlgolimabProlgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma[1]. |
| Name | Prolgolimab |
|---|
| Description | Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma[1]. |
|---|---|
| Related Catalog | |
| Target |
PD-1[1] |
| In Vitro | Prolgolimab is an IgG1 anti-PD-1 mAb that contains the Fc-silencing LALA mutation, which provides an immunopotentiating advantage by abolishing the interaction between the Fcregion of the antibody and FcgR expressed on various immune cells, thus blocking the possible effector functions of the antibody[1]. |
| References |
| No Any Chemical & Physical Properties |